CELEX: C2003/019/53
Language: en
Date: 2003-01-25 00:00:00
Title: Judgment of the Court of First Instance of 26 November 2002 in Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00, T-132/00, T-137/00 and T-141/00: Artegodan GmbH and Others v Commission of the European Communities (Medicinal products for human use — Community arbitration procedures — Withdrawal of marketing authorisations — Competence — Criteria for withdrawal — Anorectics: amfepramone, clobenzorex, fenproporex, norpseudoephedrine, phentermine — Directives 65/65/EEC and 75/319/EEC)

25.1.2003               EN                       Official Journal of the European Communities                                            C 19/29
1.     Dismisses the applications;                                          applicant in Case T-132/00, Cambridge Healthcare Supplies
                                                                            Ltd, established in Norfolk (United Kingdom), represented by
2.     Orders the applicants to pay their own costs together with those     D. Vaughan, K. Bacon, barristers, and S. Davis, solicitor, with
       of the Commission.                                                   an address for service in Luxembourg, applicant in Case T-137/
                                                                            00, Laboratoires pharmaceutiques Trenker SA, established in
                                                                            Brussels, represented by L. Defalque and X. Leurquin, lawyers,
( 1) OJ C 79 of 18.3.2000.                                                  with an address for service in Luxembourg, applicant in Case
                                                                            T-141/00, v Commission of the European Communities
                                                                            (Agents: H. Støvlbæk, R. Wainwright and B. Wägenbaur):
                                                                            Application for annulment of the Commission decisions of
                                                                            9 March 2000 concerning the withdrawal of marketing
                                                                            authorisations of medicinal products for human use containing
                                                                            respectively ‘amfepramone’ (C(2000) 453), as regards Cases
     JUDGMENT OF THE COURT OF FIRST INSTANCE                                T-74/00, T-76/00 and T-141/00, inter alia‘norpseudoephedri-
                                                                            ne’, ‘clobenzorex’ and ‘fenproporex’ (C(2000) 608), as regards
                      of 26 November 2002                                   Cases T-83/00 to T-85/00, and ‘phentermine’ (C(2000) 452),
                                                                            as regards Cases T-132/00 and T-137/00, the Court of First
                                                                            Instance (Second Chamber, Extended Composition), composed
in Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00,                       of: R.M. Moura Ramos, President, V. Tiili, J. Pirrung, P. Men-
T-132/00, T-137/00 and T-141/00: Artegodan GmbH and                         gozzi and A.W.H. Meij, Judges; D. Christensen, Administrator,
   Others v Commission of the European Communities (1)                      for the Registrar, has given a judgment on 26 November 2002,
                                                                            in which it:
(Medicinal products for human use — Community arbi-
tration procedures — Withdrawal of marketing authoris-
                                                                            1.     Annuls the Commission Decisions of 9 March 2000 (C(2000)
ations — Competence — Criteria for withdrawal — Anorect-                           452, C(2000) 453 and C(2000) 608) in so far as they relate
ics: amfepramone, clobenzorex, fenproporex, norpseudoephe-
                                                                                   to the medicinal products marketed by the applicants;
drine, phentermine — Directives 65/65/EEC and 75/319/
                                 EEC)
                                                                            2.     Orders the Commission to pay all the costs, including those
                                                                                   incurred in the interlocutory proceedings.
                           (2003/C 19/53)
          (Language of the case: German, English and French)                (1 ) OJ C 149 of 27.5.2000, C 163 of 10.6.2000, C 192 of 8.7.2000
                                                                                 and C 233 of 12.8.2000.
In Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00, T-132/
00, T-137/00 and T- 141/00, Artegodan GmbH, established
in Lüchow (Germany), represented by U. Doepner, lawyer,
with an address for service in Luxembourg, applicant in Case
T-74/00, Bruno Farmaceutici SpA, established in Rome (Italy),
Essential Nutrition Ltd, established in Brough (United                           JUDGMENT OF THE COURT OF FIRST INSTANCE
Kingdom), Hoechst Marion Roussel Ltd, established in Denham
(United Kingdom), Hoechst Marion Roussel SA, established in
Brussels (Belgium), Marion Merell SA, established in Puteaux                                         of 22 October 2002
(France), Marion Merell SA, established in Barcelona (Spain),
Sanova Pharma GmbH, established in Vienna (Austria),                        in Joined Cases T-178/00 and T-341/00, Jan Pflugradt v
Temmler Pharma GmbH & Co. KG, established in Marburg                                             European Central Bank (1)
(Germany), represented by B. Sträter and M. Ambrosius,
lawyers, with an address for service in Luxembourg, applicants
in Case T-76/00, Schuck GmbH, established in Schwaig                        (Staff of the European Central Bank — Amendment of
(Germany), represented by B. Sträter and M. Ambrosius,                              employment contract — Performance appraisal)
lawyers, with an address for service in Luxembourg, applicant
in Case T-83/00, Laboratórios Roussel Lda , established in Mem                                          (2003/C 19/54)
Martins (Portugal), represented by B. Sträter and M. Ambrosius,
lawyers, with an address for service in Luxembourg, applicant
in Cases T-84/00 and T-85/00, Laboratoires Roussel Diamant                                      (Language of the case: German)
SARL, established in Puteaux (France), represented by B. Sträter
and M. Ambrosius, lawyers, with an address for service in
Luxembourg, applicant in Case T-84/00, Roussel Iberica SA,
established in Barcelona (Spain), represented by B. Sträter                 In Joined Cases T-178/00 and T-341/00, Jan Pflugradt, residing
and M. Ambrosius, lawyers, with an address for service in                   in Frankfurt am Main (Germany), represented in Case T-178/
Luxembourg, applicant in Case T-85/00, Gerot Pharmazeutika                  00 by N. Pflüger, lawyer, and in Case T-341/00 by N. Pflüger,
GmbH, established in Vienna (Austria), represented by K. Grig-              R. Steiner and S. Mittländer, lawyers, with an address for
kar, lawyer, with an address for service in Luxembourg,                     service in Luxembourg, v European Central Bank (Agents: in